FindTrial
Sign In

Imbalanced immune homeostasis in ARDS and its outcomes

Imbalanced immune homeostasis in ARDS and its outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060839
Enrollment
Unknown
Registered
2022-06-12
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS

Interventions

case series:Nil

Sponsors

The Second Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adults patients of ARDS in intensive care units in our hospital between Jan.1st,2011- Dec.31st,2020.

Exclusion criteria

Exclusion criteria: 1. Patients whose medical records are incomplete or inaccurate; 2. Severe immunosuppression 3. End-stage of malignant tumor; 4. Died in 24 hours after admitted in ICU; 5. Pregnancy or breastfeeding; 6. Aged < 18 years.

Design outcomes

Primary

MeasureTime frame
Total mechanical ventilation;ICU length of stay;hospital length of stay;ICU mortality;Hospital mortality;—

Countries

China

Contacts

Public ContactTian Baoping
tianbp@zju.edu.cn+86 18768140793

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026